Pegalan, Florenda .
HRN: 11-63-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2022
CEFUROXIME 500MG (TAB)
08/12/2022
08/19/2022
PO
500 Mg
BID
NSVD With 1° Degree Perineorraphy
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes